Diabetes drugs that have also been used to promote weight loss, such as Novo Nordisk’s Ozempic, are being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease. Diabetes regimens, from Ozempic to old mainstays like insulin and metformin, appear to address several different aspects of the …
Read More »